NLIGHT is part of the semiconductors industry and is part of the technology sector. The company CEO is Scott H. Keeney. nLight Inc manufactures high-power semiconductor and fiber lasers. It offers semiconductor lasers, optical fibers and marking lasers.
Previous Intraday Performance:
The LASR shares had a previous change of -3.89% which opened at 18.68 and closed at 18.06. It moved to an intraday high of 19.19 and a low of 17.90.
Over the last five trading days, LASR shares returned -6.28% and in the past 30 trading days it returned -30.88%. Over three months, it changed -14.85%. In one year it has changed -49.27% and within that year its 52 week high was 43.63 and its 52 week low was 16.25. LASR stock is 11.14% above its 52 week low.
Our calculations result in a 200 day moving average of 21.46 and a 50 day moving average of 22.82. Right now, LASR stock is trading -15.83% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
The company has a market cap of $668.3m with 37.0m shares outstanding and a float of 36.6m shares. Trading volume was 347,197 shares and has experienced an average volume of 331,464 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for NLIGHT was 0.26 which ended on 31st of December 2018, which according to the previous close, that is a PE of 69.46. Based on 3 analyst estimates, the consensus EPS for the next quarter is -0.03. The trailing twelve month EPS reported is 0.27 (trailing twelve month diluted EPS is 0.24).
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr 2019||Reported 05-08-2019:||-0.03|
|4th||Qtr 2018||Reported 02-20-2019:||0.06|
The long-term trend of the EPS is an important number as it indicates the present value of NLIGHT; the EPS growth rate, as it is usually called, is typically displayed as a percentage, which at this time is hard to estimate, but revenue growth has been 14.90% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 1.10% of insider ownership.
The beta was calculated to be 2.04.
SeekingAlpha: Intra-Cellular Therapies beats by $0.24
Based on last reported financials, the company’s return on assets is 4.51%, profit margin is 5.13%, price-to-sales is 3.65 and price-to-book is 3.18.
Company Score Card:
Results are out of six:
4 : Growth Expectations Result
5 : Financial Safety Result
1 : Past Performance Result
0 : Valuation Result
0 : Dividend Safety Result
2 : Overall Result